Trial Profile
A prospective, open label, study to assess the efficacy of alfuzosin 10mg tablet once a day in male subjects suffering from benign prostate hypertrophy associated lower urinary tract symptoms and erectile dysfunction.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Aug 2022
Price :
$35
*
At a glance
- Drugs Alfuzosin (Primary)
- Indications Benign prostatic hyperplasia; Erectile dysfunction
- Focus Therapeutic Use
- 10 Aug 2022 Status changed from recruiting to completed.
- 22 Sep 2006 New trial record.